Morningstar Investment Services LLC Grifols Sa Transaction History

Morningstar Investment Services LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$7.71 - $11.56 $124,061 - $186,011	16,091 New	16,091 $169,000
Q1 2020 May 04, 2020	SELL	$16.28 - $25.63 $199,283 - $313,736	-12,241 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$19.57 - $23.52 $48,494 - $58,282	-2,478 Reduced 16.84%	12,241 $285,000
Q3 2019 Nov 12, 2019	SELL	$19.85 - $22.76 $30,985 - $35,528	-1,561 Reduced 9.59%	14,719 $295,000
Q2 2019 Aug 13, 2019	SELL	$17.59 - $21.1 $10,800 - $12,955	-614 Reduced 3.63%	16,280 $344,000
Q1 2019 May 13, 2019	SELL	$18.01 - $20.11 $51,436 - $57,434	-2,856 Reduced 14.46%	16,894 $340,000
Q4 2018 Feb 14, 2019	SELL	$17.44 - $21.53 $1,761 - $2,174	-101 Reduced 0.51%	19,750 $363,000
Q3 2018 Nov 08, 2018	SELL	$19.97 - $21.96 $21,647 - $23,804	-1,084 Reduced 5.18%	19,851 $424,000
Q2 2018 Aug 03, 2018	BUY	$20.16 - $24.68 $9,838 - $12,043	488 Added 2.39%	20,935 $450,000
Q1 2018 May 10, 2018	BUY	$20.31 - $24.95 $31,663 - $38,897	1,559 Added 8.25%	20,447 $433,000
Q4 2017 Feb 08, 2018	BUY	$20.99 - $23.89 $49,347 - $56,165	2,351 Added 14.22%	18,888 $433,000
Q3 2017 Nov 09, 2017	BUY	$20.07 - $21.89 $331,897 - $361,994	16,537	16,537 $362,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

Stay updated on Morningstar Investment Services LLC with notifications on news.